2m 2m 2m 2m 2m 2m 2m
FIBROBIOLOGICS (FBLG)
NASDAQ
$1.05-$0.005 (-0.48%)
Price as of Jun 03, 2026 6:23 PM EDT- $6.0MMarket Cap
- -93.34%1-Year Change
- BiotechnologyIndustry
FIBROBIOLOGICS (FBLG)
$1.05-$0.005 (-0.48%)
FBLG | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.05 | ||
Change | -$0.07 (-6.25%) | ||
Open | $1.13 | ||
High | $1.13 | ||
Low | $1.05 | ||
Previous Close | $1.12 | ||
Volume | 101,840 | ||
30-Day Average Volume | 346,616 | ||
1-Week Change | -0.94% | ||
1-Month Change | -28.08% | ||
1-Year Change | -93.34% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 5.2M | ||
Total Assets | $5.9M | ||
Market Cap | $6.0M | ||
Enterprise Value | $4.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$5.0M | ||
Free Cash Flow | -$4.4M | ||
EBIT | -$5.0M | ||
EBITDA | -$4.9M | ||
Net Working Capital | $1.1M | ||
EPS | -$1.33 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 03/30/2026 | ||
Earnings & Revenue